Stocks
CVS Health Corporation Financial Statements (CVS) |
||||||||||
| CVS Health Corporationsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 18.02.2020 | 16.02.2021 | 09.02.2022 | 08.02.2023 | 07.02.2024 | 06.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 256 776 | 268 706 | 292 111 | 321 629 | 357 776 | 368 280 | |||
| Operating Income, bln rub | 11 987 | 13 911 | 13 193 | 15 742 | 13 743 | 9 384 | ||||
| EBITDA, bln rub | ? | 16 348 | 17 083 | 17 401 | 12 332 | 18 178 | 14 178 | |||
| Net profit, bln rub | ? | 6 634 | 7 179 | 8 001 | 4 311 | 8 344 | 5 016 | |||
| OCF, bln rub | ? | 12 848 | 15 865 | 18 265 | 16 177 | 13 426 | 4 611 | |||
| CAPEX, bln rub | ? | 2 457 | 2 437 | 2 520 | 2 727 | 3 031 | 2 924 | |||
| FCF, bln rub | ? | 10 391 | 13 428 | 15 745 | 13 450 | 10 395 | 1 687 | |||
| Dividend payout, bln rub | 2 603 | 2 624 | 2 625 | 2 907 | 3 132 | 3 314 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 39.2% | 36.6% | 32.8% | 67.4% | 37.5% | 66.1% | ||||
| OPEX, bln rub | 33 541 | 35 135 | 37 066 | 46 379 | 40 688 | 41 498 | ||||
| Cost of production, bln rub | 211 248 | 219 660 | 240 063 | 267 965 | 303 345 | 316 534 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 3 035 | 2 907 | 2 503 | 2 287 | 2 658 | 2 890 | ||||
| Assets, bln rub | 222 449 | 230 715 | 232 999 | 228 275 | 249 728 | 252 427 | ||||
| Net Assets, bln rub | ? | 63 864 | 69 389 | 75 075 | 71 015 | 76 461 | 74 944 | |||
| Debt, bln rub | 89 002 | 85 042 | 75 999 | 70 732 | 79 385 | 82 704 | ||||
| Cash, bln rub | 8 056 | 10 854 | 12 525 | 15 723 | 11 455 | 6 875 | ||||
| Net debt, bln rub | 80 946 | 74 188 | 63 474 | 55 009 | 67 930 | 75 829 | ||||
| Ordinary share price, rub | 74.3 | 68.3 | 103.2 | 93.2 | 79.0 | 69.7 | ||||
| Number of ordinary shares, mln | 1 301 | 1 309 | 1 319 | 1 312 | 1 285 | 1 259 | ||||
| Market cap, bln rub | 96 651 | 89 405 | 136 068 | 122 265 | 101 464 | 87 715 | ||||
| EV, bln rub | ? | 177 597 | 163 593 | 199 542 | 177 274 | 169 394 | 163 544 | |||
| Book value, bln rub | -49 006 | -41 305 | -33 072 | -31 889 | -44 045 | -44 145 | ||||
| EPS, rub | ? | 5.10 | 5.48 | 6.07 | 3.29 | 6.49 | 3.98 | |||
| FCF/share, rub | 7.99 | 10.3 | 11.9 | 10.3 | 8.09 | 1.34 | ||||
| BV/share, rub | -37.7 | -31.6 | -25.1 | -24.3 | -34.3 | -35.1 | ||||
| EBITDA margin, % | ? | 6.37% | 6.36% | 5.96% | 3.83% | 5.08% | 3.85% | |||
| Net margin, % | ? | 2.58% | 2.67% | 2.74% | 1.34% | 2.33% | 1.36% | |||
| FCF yield, % | ? | 10.8% | 15.0% | 11.6% | 11.0% | 10.2% | 1.92% | |||
| ROE, % | ? | 10.4% | 10.3% | 10.7% | 6.07% | 10.9% | 6.69% | |||
| ROA, % | ? | 2.98% | 3.11% | 3.43% | 1.89% | 3.34% | 1.99% | |||
| P/E | ? | 14.6 | 12.5 | 17.0 | 28.4 | 12.2 | 17.5 | |||
| P/FCF | 9.30 | 6.66 | 8.64 | 9.09 | 9.76 | 52.0 | ||||
| P/S | ? | 0.38 | 0.33 | 0.47 | 0.38 | 0.28 | 0.24 | |||
| P/BV | ? | -1.97 | -2.16 | -4.11 | -3.83 | -2.30 | -1.99 | |||
| EV/EBITDA | ? | 10.9 | 9.58 | 11.5 | 14.4 | 9.32 | 11.5 | |||
| Debt/EBITDA | 4.95 | 4.34 | 3.65 | 4.46 | 3.74 | 5.35 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.96% | 0.91% | 0.86% | 0.85% | 0.85% | 0.79% | ||||
| CVS Health Corporation shareholders | ||||||||||
